Basel, Switzerland

Martina Thier

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: University of Michigan. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martina Thier. Retrieved from https://idiyas.com/inventor/martina-thier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martina Thier: Innovator in Chronic Kidney Disease Research

Introduction

Martina Thier is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of chronic kidney disease (CKD) through her innovative research and patented methodologies. Her work focuses on identifying biomarkers that can predict the progression of CKD, which is crucial for improving patient outcomes.

Latest Patents

Martina Thier holds a patent for "Biomarkers and methods for progression prediction for chronic kidney disease." This invention involves the detection of levels of various biomarkers, including NTpro BNP, EGF, Apo H, GDF-15, and the albumin-to-creatinine ratio. The methods developed by Thier are designed to identify individuals at increased risk of CKD progression and to monitor the effectiveness of CKD therapies. She has 1 patent to her name.

Career Highlights

Martina Thier is affiliated with the University of Michigan, where she continues her research in the field of kidney disease. Her work has garnered attention for its potential to transform the way chronic kidney disease is monitored and treated.

Collaborations

Some of her notable coworkers include Viji Nair and Maria Chiara Magnone, who have collaborated with her on various research projects related to CKD.

Conclusion

Martina Thier's innovative work in chronic kidney disease research highlights the importance of biomarkers in predicting disease progression and monitoring treatment. Her contributions are paving the way for advancements in patient care and treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…